{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:07:57Z","timestamp":1789772877695,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG058773"],"award-info":[{"award-number":["R01AG058773"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG052560"],"award-info":[{"award-number":["R01AG052560"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["K01EB023312"],"award-info":[{"award-number":["K01EB023312"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11307-020-01567-9","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T18:04:15Z","timestamp":1606759455000},"page":"372-381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Quantification of SV2A Binding in Rodent Brain Using [18F]SynVesT-1 and PET Imaging"],"prefix":"10.1007","volume":"23","author":[{"given":"Pragalath","family":"Sadasivam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian T.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Toyonaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supum","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Spurrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Strittmatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2005-6760","authenticated-orcid":false,"given":"Zhengxin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"key":"1567_CR1","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1523\/JNEUROSCI.14-09-05223.1994","volume":"14","author":"SM Bajjalieh","year":"1994","unstructured":"Bajjalieh SM, Frantz GD, Weimann JM, McConnell SK, Scheller RH (1994) Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci 14:5223\u20135235","journal-title":"J Neurosci"},{"key":"1567_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neulet.2018.07.038","volume":"691","author":"Z Cai","year":"2019","unstructured":"Cai Z, Li S, Matuskey D, Nabulsi N, Huang Y (2019) PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases. Neuroscience Letters 691:44\u201350","journal-title":"Neuroscience Letters"},{"key":"1567_CR3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41467-019-09562-7","volume":"10","author":"SE Holmes","year":"2019","unstructured":"Holmes SE, Scheinost D, Finnema SJ, Naganawa M, Davis MT, DellaGioia N, Nabulsi N, Matuskey D, Angarita GA, Pietrzak RH, Duman RS, Sanacora G, Krystal JH, Carson RE, Esterlis I (2019) Lower synaptic density is associated with depression severity and network alterations. Nat Commun 10:1529","journal-title":"Nat Commun"},{"key":"1567_CR4","doi-asserted-by":"publisher","first-page":"348ra396","DOI":"10.1126\/scitranslmed.aaf6667","volume":"8","author":"SJ Finnema","year":"2016","unstructured":"Finnema SJ, Nabulsi NB, Eid T et al (2016) Imaging synaptic density in the living human brain. Sci Transl Med 8:348ra396","journal-title":"Sci Transl Med"},{"key":"1567_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41467-019-14122-0","volume":"11","author":"EC Onwordi","year":"2020","unstructured":"Onwordi EC, Halff EF, Whitehurst T, Mansur A, Cotel MC, Wells L, Creeney H, Bonsall D, Rogdaki M, Shatalina E, Reis Marques T, Rabiner EA, Gunn RN, Natesan S, Vernon AC, Howes OD (2020) Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Nat Commun 11:246","journal-title":"Nat Commun"},{"key":"1567_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ana.25682","volume":"87","author":"D Matuskey","year":"2020","unstructured":"Matuskey D, Tinaz S, Wilcox KC, Naganawa M, Toyonaga T, Dias M, Henry S, Pittman B, Ropchan J, Nabulsi N, Suridjan I, Comley RA, Huang Y, Finnema SJ, Carson RE (2020) Synaptic changes in Parkinson disease assessed with in vivo imaging. Ann Neurol 87:329\u2013338","journal-title":"Ann Neurol"},{"key":"1567_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2967\/jnumed.115.168179","volume":"57","author":"NB Nabulsi","year":"2016","unstructured":"Nabulsi NB, Mercier J, Holden D, Carre S, Najafzadeh S, Vandergeten MC, Lin SF, Deo A, Price N, Wood M, Lara-Jaime T, Montel F, Laruelle M, Carson RE, Hannestad J, Huang Y (2016) Synthesis and preclinical evaluation of 11C-UCB-J as a PET tracer for imaging the synaptic vesicle glycoprotein 2A in the brain. J Nucl Med 57:777\u2013784","journal-title":"J Nucl Med"},{"key":"1567_CR8","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/alz.12097","volume":"16","author":"AP Mecca","year":"2020","unstructured":"Mecca AP, Chen M-K, O'Dell RS, Naganawa M, Toyonaga T, Godek TA, Harris JE, Bartlett HH, Zhao W, Nabulsi NB, Wyk BCV, Varma P, Arnsten AFT, Huang Y, Carson RE, Dyck CH (2020) In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET. Alzheimer\u2019s & Dementia 16:974\u2013982","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"1567_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","volume":"75","author":"M-K Chen","year":"2018","unstructured":"Chen M-K, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Lin SF, Najafzadeh S, Ropchan J, Lu Y, McDonald JW, Michalak HR, Nabulsi NB, Arnsten AFT, Huang Y, Carson RE, van Dyck CH (2018) Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging. JAMA Neurology 75:1215\u20131224","journal-title":"JAMA Neurology"},{"key":"1567_CR10","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.2967\/jnumed.118.223867","volume":"60","author":"T Toyonaga","year":"2019","unstructured":"Toyonaga T, Smith LM, Finnema SJ, Gallezot JD, Naganawa M, Bini J, Mulnix T, Cai Z, Ropchan J, Huang Y, Strittmatter SM, Carson RE (2019) In vivo synaptic density imaging with 11C-UCB-J detects treatment effects of saracatinib in a mouse model of Alzheimer disease. J Nucl Med 60:1780\u20131786","journal-title":"J Nucl Med"},{"key":"1567_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1021\/acschemneuro.9b00618","volume":"11","author":"Z Cai","year":"2020","unstructured":"Cai Z, Li S, Zhang W, Pracitto R, Wu X, Baum E, Finnema SJ, Holden D, Toyonaga T, Lin SF, Lindemann M, Shirali A, Labaree DC, Ropchan J, Nabulsi N, Carson RE, Huang Y (2020) Synthesis and preclinical evaluation of an (18)F-labeled synaptic vesicle glycoprotein 2A PET imaging probe: [(18)F]SynVesT-2. ACS Chem Neurosci 11:592\u2013603","journal-title":"ACS Chem Neurosci"},{"key":"1567_CR12","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1021\/acschemneuro.8b00526","volume":"10","author":"S Li","year":"2019","unstructured":"Li S, Cai Z, Wu X, Holden D, Pracitto R, Kapinos M, Gao H, Labaree D, Nabulsi N, Carson RE, Huang Y (2019) Synthesis and in vivo evaluation of a novel PET radiotracer for imaging of synaptic vesicle glycoprotein 2A (SV2A) in nonhuman primates. ACS Chem Neurosci 10:1544\u20131554","journal-title":"ACS Chem Neurosci"},{"key":"1567_CR13","doi-asserted-by":"publisher","unstructured":"Naganawa M, Li S, Nabulsi NB, Henry S, Zheng MQ, Pracitto R, Cai Z, Gao H, Kapinos M, Labaree D, Matuskey D, Huang Y, Carson RE (2020) First-in-human evaluation of 18F-SynVesT-1, a novel radioligand for PET imaging of synaptic vesicle protein 2A. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.120.249144","DOI":"10.2967\/jnumed.120.249144"},{"key":"1567_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2003","unstructured":"Jankowsky JL, Fadale DJ, Anderson J et al (2003) Mutant presenilins specifically elevate the levels of the 42 residue \u03b2-amyloid peptide in vivo: evidence for augmentation of a 42-specific \u03b3 secretase. Human Molecular Genetics 13:159\u2013170","journal-title":"Human Molecular Genetics"},{"key":"1567_CR15","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0395-10.2010","volume":"30","author":"DA Gimbel","year":"2010","unstructured":"Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Lauren J, Gimbel ZA, Strittmatter SM (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 30:6367\u20136374","journal-title":"J Neurosci"},{"key":"1567_CR16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.3178","volume":"15","author":"JW Um","year":"2012","unstructured":"Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM (2012) Alzheimer amyloid-\u03b2 oligomer bound to post-synaptic prion protein activates Fyn to impair neurons. Nature Neuroscience 15:1227\u20131235","journal-title":"Nature Neuroscience"},{"key":"1567_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.neuron.2013.10.001","volume":"80","author":"W Um Ji","year":"2013","unstructured":"Um Ji W, Kaufman Adam C, Kostylev M et al (2013) Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer A\u03b2 oligomer bound to cellular prion protein. Neuron 80:531","journal-title":"Neuron"},{"key":"1567_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153\u2013158","journal-title":"Neuroimage"},{"key":"1567_CR19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","volume":"16","author":"J Logan","year":"1996","unstructured":"Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834\u2013840","journal-title":"J Cereb Blood Flow Metab"},{"key":"1567_CR20","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1111\/j.1528-1167.2009.02089.x","volume":"50","author":"RM Kaminski","year":"2009","unstructured":"Kaminski RM, Gillard M, Leclercq K, Hanon E, Lorent G, Dassesse D, Matagne A, Klitgaard H (2009) Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam. Epilepsia 50:1729\u20131740","journal-title":"Epilepsia"},{"key":"1567_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejphar.2011.04.064","volume":"664","author":"M Gillard","year":"2011","unstructured":"Gillard M, Fuks B, Leclercq K, Matagne A (2011) Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties. Eur J Pharmacol 664:36\u201344","journal-title":"Eur J Pharmacol"},{"key":"1567_CR22","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s11307-019-01428-0","volume":"22","author":"S Patel","year":"2019","unstructured":"Patel S, Knight A, Krause S et al (2019) Preclinical in vitro and in vivo characterization of synaptic vesicle 2A-Targeting compounds amenable to F-18 labeling as potential pet radioligands for imaging of synapse integrity. Mol Imaging Biol. 22:832\u2013841","journal-title":"Mol Imaging Biol."},{"key":"1567_CR23","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101:9861\u20139866","journal-title":"Proc Natl Acad Sci USA"},{"key":"1567_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/cmdc.201300482","volume":"9","author":"J Mercier","year":"2014","unstructured":"Mercier J, Archen L, Bollu V, Carr\u00e9 S, Evrard Y, Jnoff E, Kenda B, Lallemand B, Michel P, Montel F, Moureau F, Price N, Quesnel Y, Sauvage X, Valade A, Provins L (2014) Discovery of heterocyclic nonacetamide synaptic vesicle protein 2A (SV2A) ligands with single-digit nanomolar potency: opening avenues towards the first SV2A positron emission tomography (PET) ligands. ChemMedChem 9:693\u2013698","journal-title":"ChemMedChem"},{"key":"1567_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.nucmedbio.2016.03.004","volume":"43","author":"S Estrada","year":"2016","unstructured":"Estrada S, Lubberink M, Thibblin A, Sprycha M, Buchanan T, Mestdagh N, Kenda B, Mercier J, Provins L, Gillard M, Tytgat D, Antoni G (2016) [11C]UCB-A, a novel PET tracer for synaptic vesicle protein 2 A. Nucl Med Biol 43:325\u2013332","journal-title":"Nucl Med Biol"},{"key":"1567_CR26","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.2967\/jnumed.113.136143","volume":"55","author":"GI Warnock","year":"2014","unstructured":"Warnock GI, Aerts J, Bahri MA, Bretin F, Lemaire C, Giacomelli F, Mievis F, Mestdagh N, Buchanan T, Valade A, Mercier J, Wood M, Gillard M, Seret A, Luxen A, Salmon E, Plenevaux A (2014) Evaluation of 18F-UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain. J Nucl Med 55:1336\u20131341","journal-title":"J Nucl Med"},{"key":"1567_CR27","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, Lemere CA, Selkoe DJ, Stevens B (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352:712\u2013716","journal-title":"Science"},{"key":"1567_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neuroscience.2012.05.050","volume":"251","author":"J Pozueta","year":"2013","unstructured":"Pozueta J, Lefort R, Shelanski ML (2013) Synaptic changes in Alzheimer\u2019s disease and its models. Neuroscience 251:51\u201365","journal-title":"Neuroscience"},{"key":"1567_CR29","unstructured":"Bertoglio D, Verhaeghe J, Miranda A, et al. (2019) Validation and noninvasive kinetic modeling of [(11)C]UCB-J PET imaging in mice. J Cereb Blood Flow Metab 0:271678X19864081."},{"key":"1567_CR30","doi-asserted-by":"publisher","unstructured":"Naganawa M, Gallezot J-D, Finnema S, Matuskey D, Mecca AP, Nabulsi NB, Labaree D, Ropchan J, Malison RT, D'Souza DC, Esterlis I, Detyniecki K, van Dyck CH, Huang Y, Carson RE (2020) Simplified quantification of 11C-UCB-J PET evaluated in a large human cohort. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.120.243949","DOI":"10.2967\/jnumed.120.243949"},{"issue":"4","key":"1567_CR31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1021\/acschemneuro.9b00618","volume":"11","author":"Z Cai","year":"2020","unstructured":"Cai Z, Li S, Zhang W et al (2020) Synthesis and preclinical evaluation of an 18F-labeled synaptic vesicle glycoprotein 2A PET imaging probe: [18F]SynVesT-2. ACS Chem Neurosci 11(4):592\u2013603","journal-title":"ACS Chem Neurosci"},{"key":"1567_CR32","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1007\/s00259-019-04357-w","volume":"46","author":"S Li","year":"2019","unstructured":"Li S, Cai Z, Zhang W, Holden D, Lin SF, Finnema SJ, Shirali A, Ropchan J, Carre S, Mercier J, Carson RE, Nabulsi N, Huang Y (2019) Synthesis and in vivo evaluation of [(18)F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A). Eur J Nucl Med Mol Imaging 46:1952\u20131965","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1567_CR33","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1177\/0271678X19879230","volume":"40","author":"S Rossano","year":"2019","unstructured":"Rossano S, Toyonaga T, Finnema SJ et al (2019) Assessment of a white matter reference region for (11)C-UCB-J PET quantification. J Cereb Blood Flow Metab 40:1890\u20131901","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-020-01567-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-020-01567-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-020-01567-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T01:12:56Z","timestamp":1620263576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-020-01567-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1567"],"URL":"https:\/\/doi.org\/10.1007\/s11307-020-01567-9","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,30]]},"assertion":[{"value":"13 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving animals were in accordance with ethical standards of the Yale University Institutional Animal Care and Use Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}